Vincent Brichard
- Immunology top 0.2%
- Oncology top 1%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Genetics top 10%
- Co-authors
- Thierry BoonAline Van PelThomas WölfelPierre G. CoulieEtienne De PlaenBernard LethéJamila LouahedCatherine Wölfel
- Topics
- Immunotherapy and Immune Responses (64 papers)vaccines and immunoinformatics approaches (32 papers)Cancer Immunotherapy and Biomarkers (23 papers)
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Proceedings of the National Academy of SciencesThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Vincent Brichard
70 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 4.8k
- Oncology 2.6k
- Molecular Biology 2.4k
- Radiology, Nuclear Medicine and Imaging 504
- Genetics 333
Countries citing papers authored by Vincent Brichard
This map shows the geographic impact of Vincent Brichard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Brichard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Brichard more than expected).
Fields of papers citing papers by Vincent Brichard
This network shows the impact of papers produced by Vincent Brichard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Brichard. The network helps show where Vincent Brichard may publish in the future.
Co-authorship network of co-authors of Vincent Brichard
This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Brichard. A scholar is included among the top collaborators of Vincent Brichard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Brichard. Vincent Brichard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 26 | |
| 3 | 41 | |
| 4 | 51 | |
| 5 | Clinical response to the MAGE-A3 immunotherapeutic in metastatic melanoma patients is associated with a specific gene profile present prior to treatment | 8 |
| 6 | GENE EXPRESSION SIGNATURE IS A POTENTIAL PREDICTIVE FACTOR FOR EFFICACY OF MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC) | 2 |
| 7 | 4 | |
| 8 | 120 | |
| 9 | Development of cancer vaccines with the MAGE-3 protein | 3 |
| 10 | 78 | |
| 11 | Melanoma vaccines: achievements and perspectives. | 2 |
| 12 | 25 | |
| 13 | 46 | |
| 14 | 346 | |
| 15 | 48 | |
| 16 | 179 | |
| 17 | Genes encoding human tumor-antigens recognized by cytolytic T-lymphocytes | 2 |
| 18 | 345 | |
| 19 | 42 | |
| 20 | 90 |
About Vincent Brichard
Vincent Brichard is a scholar working on Immunology, Oncology and Biotechnology, having authored 73 papers that have together received 5.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (64 papers), vaccines and immunoinformatics approaches (32 papers) and Cancer Immunotherapy and Biomarkers (23 papers). The work is most often cited by research in Immunology (4.8k citations), Oncology (2.6k citations) and Molecular Biology (2.4k citations). Vincent Brichard has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Thierry Boon, Aline Van Pel, Thomas Wölfel, Pierre G. Coulie, Etienne De Plaen, Bernard Lethé, Jamila Louahed, Catherine Wölfel, Jean‐Christophe Renauld and Christophe Lurquin. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.